Cencora, Inc.
COR Healthcare Medical Distribution
Cencora, Inc.’s revenue for fiscal 2025 (year ended September 2025) was $321.3 billion, up 9.31% from fiscal 2024. In the quarter to June 2026, revenue grew 5.07%, EPS grew 11.3%, free cash flow grew 3,385.3% and total debt rose 42.3%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for three consecutive years, revenue growth for ten; insiders bought in the last twelve months.
Follow COR
Cencora, Inc. (COR) Free cash flow margin
Cencora, Inc.'s free cash flow margin over the twelve months to 30 June 2026 was 1.23%, up 0.2 percentage points from fiscal 2025 (1.00%). Over the past ten years it has ranged from 0.64% (fiscal 2018) to 2.71% (fiscal 2015); the current reading is higher than 45% of that period. That is above the Medical Distribution industry median of 0.00% and above the Healthcare sector median of 0.00%.
Free cash flow margin, annual
Embed this chart
Annual newest first
| Period | Free cash flow margin | Change (points) |
|---|---|---|
| FY2025 | 1.00% | (0.02) |
| FY2024 | 1.02% | (0.30) |
| FY2023 | 1.32% | 0.40 |
| FY2022 | 0.92% | (0.12) |
| FY2021 | 1.04% | 0.05 |
| FY2020 | 0.99% | (0.14) |
| FY2019 | 1.13% | 0.49 |
| FY2018 | 0.64% | (0.04) |
| FY2017 | 0.68% | (1.17) |
| FY2016 | 1.85% | (0.86) |
Against its own ten years
Free cash flow margin against peers
| Company | Free cash flow margin |
|---|---|
| HSIC Henry Schein, Inc. compare | 4.18% |
| CAH Cardinal Health, Inc. compare | 1.79% |
| MCK McKesson Corporation compare | 1.50% |
| COR Cencora, Inc. | 1.23% |
| AHG Akso Health Group Sponsored ADR compare | 0.00% |
| HKPD Cellyan Biotechnology Co., Ltd compare | 0.00% |
| ACH Accendra Health, Inc. compare | −7.97% |
| COSM Cosmos Health Inc. compare | −16.9% |
| FOCL FocalTherics compare | −24.6% |
| Medical Distribution industry median | 0.00% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Free cash flow margin is
Free Cash Flow Margin tells an investor how much of each sale turns into cash the company keeps after paying for investment in its assets.
(Operating Cash Flow + Property, Plant, Equipment Change (Net) + Intangible Assets Change (Net)) ÷ Revenue
More on COR
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement